Related Experiment Video
Updated: Aug 20, 2026

Studying Wnt Signaling During Patterning of Conducting Airways
Published on: October 16, 2016
Expression and activity of beta-defensins and LL-37 in the developing human lung
Timothy D Starner1, Birgitta Agerberth, Gudmundur H Gudmundsson
1Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA. timothy-starner@uiowa.edu
Insights
Human beta-defensins (HBDs) are key to neonatal lung immunity. Lower HBD-2 levels in premature infants may increase their susceptibility to pulmonary infections.
Area of Science:
- Immunology
- Neonatal Medicine
- Pulmonology
Background:
- Neonatal innate immunity is immature, increasing infection susceptibility.
- The lung is a primary pathogen entry point in neonates.
- Human beta-defensins (HBDs) and LL-37 are crucial for pulmonary innate immunity.
Purpose of the Study:
- To investigate the developmental regulation and expression of HBDs and LL-37 in neonatal pulmonary tissues.
- To determine the role of these antimicrobial factors in neonatal innate immunity.
- To assess the antimicrobial activity of HBDs against neonatal sepsis-causing bacteria.
Main Methods:
- Analysis of HBD-2, HBD-1, HBD-3, and LL-37 mRNA expression in neonatal lung and airway epithelial cultures.
- Investigation of the effects of IL-1beta and dexamethasone on HBD expression.
- Quantification of HBD-2 in neonatal tracheal aspirates.
- Assessment of antimicrobial activity and salt sensitivity of HBDs.
Main Results:
- HBD-2 was the predominant beta-defensin in the neonatal lung.
- HBD-2 expression was developmentally regulated, induced by IL-1beta, and suppressed by dexamethasone.
- HBD-2 levels in tracheal aspirates correlated positively with gestational age.
- HBD-1 expression was lower than HBD-2 and induced by dexamethasone.
- HBD-3 and LL-37 were not detected in airway epithelial cultures.
- Each antimicrobial peptide displayed distinct antimicrobial activity and salt sensitivity.
Conclusions:
- HBD-2 is a key developmentally regulated antimicrobial factor in the neonatal lung.
- Decreased HBD-2 levels in premature infants may contribute to their heightened susceptibility to pulmonary infections.
- These findings highlight the importance of HBDs in neonatal pulmonary defense.
Abstract:
Immaturity of innate immunity contributes to the increased susceptibility of human neonates to infection. The lung is a major portal of entry for potential pathogens in the neonate, and human beta-defensins (HBDs) and LL-37 participate in pulmonary innate immunity. We hypothesized that these antimicrobial factors would be developmentally regulated, expressed by neonatal pulmonary tissues, and participate in neonatal innate immunity. We found HBD-2 to be the predominant beta-defensin in human neonatal lung. HBD-2 mRNA expression was developmentally regulated, induced by the proinflammatory factor IL-1beta, and decreased by dexamethasone. Additionally, HBD-2 abundance in neonatal tracheal aspirates increased as a function of gestational age. HBD-1 had a lower level of expression compared with HBD-2 and was induced by dexamethasone. HBD-3 and LL-37 messages were not detected in airway epithelial cultures. Additionally, each antimicrobial peptide exhibited a unique spectrum of antimicrobial activity and salt sensitivity against bacteria commonly causing sepsis in the neonate. Lower levels of HBD-2 may be one factor contributing to the increased susceptibility of premature infants to pulmonary infections.
More Related Videos
08:42Isolating Bronchial Epithelial Cells from Resected Lung Tissue for Biobanking and Establishing Well-Differentiated Air-Liquid Interface Cultures
Published on: May 26, 2023
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Related Concept Videos
Microbiota of the Respiratory Tract
Development of Human Microbiota